<html>
<head>PUBMED IDs for Nesprin-2</head>
<body bgcolor='#C5F0F2'><h1>Nesprin-2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15671068/'>Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle.</a> January 27  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15843432/'>Lamin A/C-dependent localization of Nesprin-2, a giant scaffolder at the nuclear envelope.</a> April 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17881656/'>Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.</a> September 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19596800/'>Nesprin-2 interacts with meckelin and mediates ciliogenesis via remodelling of the actin cytoskeleton.</a> October 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21820406/'>Nesprin-2 epsilon: a novel nesprin isoform expressed in human ovary and Ntera-2 cells.</a> October 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22198684/'>The nuclear envelope protein Nesprin-2 has roles in cell proliferation and differentiation during wound healing.</a> December 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23977161/'>Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause LINC complex alterations.</a> April 9  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24080406/'>Nonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cells.</a> March 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24375709/'>Contribution of SUN1 mutations to the pathomechanism in muscular dystrophies.</a> January 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24375709/'>Contribution of SUN1 mutations to the pathomechanism in muscular dystrophies.</a> January 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24718612/'>Nesprins: tissue-specific expression of epsilon and other short isoforms.</a> June 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26645154/'>Nesprin-2 mediated nuclear trafficking and its clinical implications.</a> November 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26645151/'>Fasting plus tyrosine kinase inhibitors in cancer.</a> October 26  2015<br></body></html>
